POSITRON CORP
POSCOTCHealthcare · Electromedical & Electrotherapeutic Apparatus · TX · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $461,452 | $587,500 | $456,000 | $371,000 | $829,000 | $6.7M |
| Operating income | −$10.5M | −$2.2M | −$2.7M | −$3.3M | −$4.7M | −$4.4M |
| Net income | −$10.6M | −$2.4M | $861,000 | $1.2M | $3.0M | −$6.1M |
| Total assets | $4.0M | $1.8M | $1.9M | $3.9M | $2.7M | $2.3M |
| Total liabilities | $2.6M | $2.5M | $2.7M | $15.1M | $8.9M | — |
| Equity | $1.4M | −$656,725 | −$837,000 | −$11.2M | −$6.2M | −$2.9M |
| EPS (diluted) | $-0.34 | $-0.09 | — | — | — | — |
| Shares out. | 32.8M | 27.3M | 1.45B | 1.45B | 1.10B | 788.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −2275.1%
- Net margin
- −2297.8%
- Return on equity
- −734.4%
- Return on assets
- −265.1%
- Return on capital (ROCE)
- −657.2%
- Liabilities / assets
- 63.9%
- Debt / equity
- 1.77×
- Book value / share
- $0.04
- Revenue growth (YoY)
- −21.5%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -133.64distress
- Accruals / assets
- −147.6%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 4 warning● 1 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 31, 2016
- NT 10-Qmissed a reporting deadline ↗Nov 16, 2015
- NT 10-Qmissed a reporting deadline ↗May 15, 2013
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2013
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2012
- NT 10-Qmissed a reporting deadline ↗May 15, 2012
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| O Brate Cecil10% owner | Aug 27, 2014 | Buy | 333.3M | $0.00 |
| Conn Corey NOfficer — Chief Financial Officer | Nov 3, 2014 | Buy | 607.2M | $0.00 |
| Rooney Patrick G | Nov 3, 2014 | Sell | 607.2M | $0.00 |
| Rooney Patrick GOfficer — Chief Executive Officer | Aug 22, 2014 | Buy | 100.0M | $0.00 |
| Conn Corey NOfficer — Chief Financial Officer | Aug 22, 2014 | Buy | 16.7M | $0.00 |
| Conn Corey NOfficer — Chief Financial Officer | Jun 30, 2014 | Buy | 69.4M | $0.00 |
| Rooney Patrick GOfficer — Chief Executive Officer | Jun 30, 2014 | Buy | 277.8M | $0.00 |
| Conn Corey NOfficer — Chief Financial Officer | May 19, 2014 | Buy | 120.0M | $0.00 |
| Rooney Patrick GOfficer — Chief Executive Officer | May 19, 2014 | Buy | 407.2M | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Apr 30, 2026 | 2,244 | 1.0 | +100.0% |
| Mar 13, 2026 | 5,978 | 1.0 | -48.9% |
| Feb 27, 2026 | 11,702 | 1.0 | +274.2% |
| Feb 13, 2026 | 3,127 | 1.0 | -70.2% |
| Jan 30, 2026 | 10,495 | 1.0 | -15.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Unregistered equity saleDec 30, 2025
- Changed auditorDec 16, 2025
- Entered a material agreement · Bankruptcy or receivership · Results of operations · Director / officer change · Shareholder voteAug 1, 2018
- Entered a material agreement · Bankruptcy or receivershipMay 10, 2016
- Director / officer changeFeb 22, 2016
- Director / officer changeOct 5, 2015
- Other material eventSep 11, 2015
- Director / officer changeDec 22, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QFORM 10-QMay 15, 2026
- 10-KFORM 10-KMar 31, 2026
- 8-KDec 30, 2025
- 8-KDec 16, 2025
- 10-12GNov 12, 2025
- 15-12GMay 2, 2019
- 8-KAug 1, 2018
- SC 13D/AJun 21, 2016
- 8-KFORM 8-KMay 10, 2016
- NT 10-KMar 31, 2016
- 8-KFORM 8-KFeb 22, 2016
- 10-QNov 23, 2015
- NT 10-QNov 16, 2015
- 8-KFORM 8-KOct 5, 2015
- 8-KFORM 8-KSep 11, 2015
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.